Discovering the Immunologic Mechanism of Ascaris-induced Allergic Airway Disease.
发现蛔虫引起的过敏性气道疾病的免疫机制。
基本信息
- 批准号:10563160
- 负责人:
- 金额:$ 18.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-02-20 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAccountingAdaptive Immune SystemAdvisory CommitteesAllergensAntigensAreaAscariasisAscarisAsthmaAttenuatedAuthorization documentationBasic ScienceCell physiologyCellsChildChild HealthChildhoodCommunicable DiseasesCommunicationComplexComprehensionDataDevelopmentDevelopment PlansDissectionEnvironmentExtrinsic asthmaFibrinogenGoalsHelper-Inducer T-LymphocyteHospitalizationHost-Parasite RelationsIgEImmuneImmune ToleranceImmune responseImmunologicsInfectionInflammatoryIngestionInnate Immune ResponseInnate Immune SystemInstructionInterleukin-13Interleukin-4Interleukin-5InterventionIntestinesInvestmentsK-Series Research Career ProgramsLaboratoriesLarvaLeadershipLigandsLinkLungMediatingMedicineMentorsMentorshipMolecularMolecular ImmunologyMorbidity - disease rateMusNematodaParasitic infectionParasitologyPathogenesisPathway interactionsPeptide HydrolasesPeripheralPersonsPhenotypePhysiciansPovertyRegulatory T-LymphocyteResearchResearch PersonnelResearch ProposalsResolutionResourcesRoleSTAT6 Transcription FactorScheduleScientistSignal TransductionSymptomsTLR4 geneTeacher Professional DevelopmentTh2 CellsTherapeuticTraining ActivityTranslational ResearchTropical MedicineUnited States National Institutes of HealthVaccinesadaptive immune responseairway hyperresponsivenessallergic airway diseaseasthma modelauthoritycareercareer developmentcollegecytokineeggfungushealth disparityhelminth infectionhigh riskimmune activationimprovedinnovationinsightmeetingsmicrobialmicrobial hostmigrationmouse modelnew therapeutic targetnovelpathogenpreventprofessorresponseskillstranslational research programvaccine development
项目摘要
Summary: Dr. Weatherhead is an Assistant Professor of Pediatric Tropical Medicine and Infectious Diseases
at Baylor College of Medicine (BCM) and a physician-scientist in the area of immunoparasitology. Her career
goal is to be an expert in parasitic health disparities and perform high-quality basic science research that
improves the health of children living in poverty. Children living in poverty are at high risk of parasitic infections
such as ascariasis, which infects over 800 million children and is associated with significant morbidity including
allergic airway disease. Dr. Weatherhead aims to dissect the complex host immune response to ascariasis in
order to highlight novel interventions that are urgently needed to prevent morbidity in children living in poverty.
Her unique skill set will allow her to serve as a link between laboratory discovery and field implementation of
newly developed anthelminthic targets. To accomplish these goals, Dr. Weatherhead has developed a
comprehensive career development plan which combines thorough mentoring and training activities integrated
into her basic and translational research program. She will have scheduled meetings with her invested
mentorship team, Dr. David Corry, an authority in molecular immunology and allergic airway disease, and Dr.
Peter Hotez, a global leader in parasitology and vaccine development. Dr. Weatherhead will receive additional
expert-level mentorship on the microbial-host immune interface from her scientific advisory committee.
Mentored research will be supplemented with formal training activities including graduate-level coursework,
participation in national scientific meetings and instruction in scientific communication and academic
leadership. Her career development plan is supported by a world-class scientific environment which offers
ample opportunities for junior faculty development and provides all the resources needed to achieve her career
goals. Dr. Weatherhead's research will evaluate the innate and adaptive immunologic mechanism by which
Ascaris larval lung migration induces allergic airway disease. The first aim will define the molecular pathway
involved in innate immune activation during pulmonary ascariasis. The second aim will determine when and for
how long the host loses peripheral immune tolerance as a result of Ascaris-induced adaptive immune
activation. Both aims will evaluate the immune pathways in the presence and absence of protease activity.
Questions outlined in this proposal are highly significant to the field of tropical medicine and parasitology
having the potential to shift our understanding of the complex parasite-host relationship, lending support to the
hypothesis that ascariasis is a leading cause of allergic airway disease in endemic regions. This proposal will
advance the comprehension of the mechanistic pathways of Ascaris-induced allergic airway disease as well as
provide therapeutic insight into asthma in general, suggesting novel interventional targets that are critically
needed to prevent morbidity in children. The mentored career development activities proposed in this
application will allow Dr. Weatherhead to evolve as an independent investigator in immunoparasitology.
摘要:Weatherhead 博士是小儿热带医学和传染病助理教授
贝勒医学院 (BCM) 博士,免疫寄生虫学领域的医师科学家。她的事业
目标是成为寄生虫健康差异方面的专家并进行高质量的基础科学研究
改善贫困儿童的健康。贫困儿童感染寄生虫的风险很高
例如蛔虫病,它感染了超过 8 亿儿童,并与多种疾病相关,包括
过敏性气道疾病。 Weatherhead 博士旨在剖析宿主对蛔虫病的复杂免疫反应
旨在强调为预防贫困儿童发病而迫切需要的新干预措施。
她独特的技能将使她能够成为实验室发现和现场实施之间的纽带
新开发的驱虫目标。为了实现这些目标,Weatherhead 博士开发了一种
全面的职业发展计划,结合了全面的指导和培训活动
进入她的基础和转化研究计划。她将与她的投资人安排会面
导师团队由分子免疫学和过敏性气道疾病领域权威David Corry博士和
Peter Hotez,寄生虫学和疫苗开发领域的全球领导者。韦瑟黑德博士将获得额外的
她的科学顾问委员会对微生物-宿主免疫界面提供专家级指导。
指导研究将辅以正式的培训活动,包括研究生水平的课程、
参加国家科学会议以及科学传播和学术指导
领导。她的职业发展计划得到了世界一流的科学环境的支持,该环境提供了
为初级教师提供充足的发展机会,并提供实现其职业生涯所需的所有资源
目标。 Weatherhead 博士的研究将评估先天性和适应性免疫机制,通过该机制
蛔虫幼虫肺部迁移诱发过敏性气道疾病。第一个目标将定义分子途径
参与肺蛔虫病期间的先天免疫激活。第二个目标将决定何时以及为了什么
宿主因蛔虫诱导的适应性免疫而失去外周免疫耐受需要多长时间
激活。这两个目标都将评估存在和不存在蛋白酶活性的情况下的免疫途径。
本提案中概述的问题对于热带医学和寄生虫学领域非常重要
有潜力改变我们对复杂的寄生虫与宿主关系的理解,为
假设蛔虫病是流行地区过敏性气道疾病的主要原因。该提案将
促进对蛔虫引起的过敏性气道疾病以及过敏性气道疾病的机制途径的理解
提供对哮喘的总体治疗见解,提出关键的新干预目标
需要预防儿童发病。本报告中提出的指导性职业发展活动
该应用程序将使 Weatherhead 博士成为免疫寄生虫学领域的独立研究者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jill Elizabeth Weatherhead其他文献
Jill Elizabeth Weatherhead的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jill Elizabeth Weatherhead', 18)}}的其他基金
Novel recombinant protein immunoassays for the diagnosis and monitoring of toxocariasis in children living in the United States.
用于诊断和监测美国儿童弓蛔虫病的新型重组蛋白免疫分析。
- 批准号:
10742436 - 财政年份:2023
- 资助金额:
$ 18.75万 - 项目类别:
Discovering the Immunologic Mechanism of Ascaris-induced Allergic Airway Disease.
发现蛔虫引起的过敏性气道疾病的免疫机制。
- 批准号:
9891681 - 财政年份:2020
- 资助金额:
$ 18.75万 - 项目类别:
Discovering the Immunologic Mechanism of Ascaris-induced Allergic Airway Disease.
发现蛔虫引起的过敏性气道疾病的免疫机制。
- 批准号:
10330576 - 财政年份:2020
- 资助金额:
$ 18.75万 - 项目类别:
相似国自然基金
上市公司所得税会计信息公开披露的经济后果研究——基于“会计利润与所得税费用调整过程”披露的检验
- 批准号:72372025
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
兔死狐悲——会计师事务所同侪CPA死亡的审计经济后果研究
- 批准号:72302197
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
环境治理目标下的公司财务、会计和审计行为研究
- 批准号:72332003
- 批准年份:2023
- 资助金额:166 万元
- 项目类别:重点项目
签字注册会计师动态配置问题研究:基于临阵换师视角
- 批准号:72362023
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
异常获利、捐赠与会计信息操纵:基于新冠疫情的准自然实验研究
- 批准号:72372061
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
相似海外基金
Immune recognition of Klebsiella pneumoniae O2v1 and O2v2 O-antigen subtypes
肺炎克雷伯菌 O2v1 和 O2v2 O 抗原亚型的免疫识别
- 批准号:
10739041 - 财政年份:2023
- 资助金额:
$ 18.75万 - 项目类别:
Early Onset Parkinson’s disease subtypes and pathogenic mechanisms
早发性帕金森病亚型及致病机制
- 批准号:
10719645 - 财政年份:2023
- 资助金额:
$ 18.75万 - 项目类别:
Antenatal Anxiety and Dyadic Immune Risk(ADIR Study)
产前焦虑和二元免疫风险(ADIR 研究)
- 批准号:
10561867 - 财政年份:2023
- 资助金额:
$ 18.75万 - 项目类别:
Goblet cells and intestinal immune response in alcohol-associated liver disease
酒精相关性肝病中的杯状细胞和肠道免疫反应
- 批准号:
10446819 - 财政年份:2022
- 资助金额:
$ 18.75万 - 项目类别: